Abstract
An immunoradiometric assay (IRMA) for the measurement of insulin-like growth factor-II (IGF-II) in human plasma has been developed, optimized and evaluated clinically in normal subjects and patients with disorders of the GH/IGF-I axis. Six monoclonal antibodies (MAbs) to recombinant human IGF-II (rhIGF-II) were produced, all of which had low cross-reactivity with rhIGF-I (
Original language | English |
---|---|
Pages (from-to) | 141-150 |
Number of pages | 9 |
Journal | Journal of Endocrinology |
Volume | 137 |
Issue number | 1 |
Publication status | Published - 1993 |